NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Pattern Bioscience

Pattern Bioscience

Private
Austin, TexasHealthcare & Life Scienceshttps://pattern.bio/

Last Round

Series D

Nov 18, 2025

Total Funding Raised

$131.85M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Pattern Bioscience is a biotechnology company that develops rapid, culture-free diagnostic technologies for identifying bacterial infections and determining antibiotic susceptibility.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

rapid diagnosticsantibiotic susceptibility testingASTphenotypic testingbacterial identificationsingle-cell analysisdigital cultureclinical diagnosticsAI diagnosticsmicrofluidicspoint of care testingPOCTrapid IDmedical deviceantibiotic stewardship

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pattern Bioscience Comparables

Compare Pattern Bioscience with similar companies based on industry and business-model similarity.

Pattern Bioscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SeLux Diagnostics
85%
Gradientech
84%
Resistell AG
83%

Pattern Bioscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DNov 18, 2025
GrantNov 21, 2024
Series CApr 27, 2023
Series B ExtensionJul 14, 2020
GrantFeb 4, 2020
Series B
Feb 4, 2020

Key People

Founding team and executive leadership

Carey-Ann Burnham

Chief Executive Officer

Executive Team

Pattern Bioscience Investors

Notable investors and investment history

Pattern Bioscience investors
InvestorRounds
AMR Action FundSeries C, Series D
CARB-XGrant
NIH RADxGrant
Omnimed CapitalSeries B Extension, Series C
Public Health Emergency Medical Countermeasures EnterpriseGrant
National Institutes of Health (NIH)Grant
Illumina VenturesSeries B Extension, Series C, Series D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Implementing NetSuite for production and order-to-cash cycle.

  • Mar 1, 2026

    Developing a Pneumonia ID/AST solution and hiring a Head of Commercial.

Pattern Bioscience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pattern Bioscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pattern Bioscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersAustin, Texas
Employee Range76
Year Founded2016
Last FundingNov 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.